Implication of Central Nervous System Barrier Impairment in Amyotrophic Lateral Sclerosis: Gender-Related Difference in Patients.

C9orf72 QAlb amyotrophic lateral sclerosis blood–brain barrier central nervous system barrier spinal cord barrier

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
07 Jul 2023
Historique:
received: 12 06 2023
revised: 03 07 2023
accepted: 05 07 2023
medline: 17 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

Central nervous system (CNS) barrier impairment has been reported in amyotrophic lateral sclerosis (ALS), highlighting its potential significance in the disease. In this context, we aim to shed light on its involvement in the disease, by determining albumin quotient (QAlb) at the time of diagnosis of ALS in a large cohort of patients. Patients from the university hospital of Tours (

Identifiants

pubmed: 37446372
pii: ijms241311196
doi: 10.3390/ijms241311196
pmc: PMC10342931
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Lancet. 2022 Oct 15;400(10360):1363-1380
pubmed: 36116464
Neurobiol Dis. 2010 Jan;37(1):13-25
pubmed: 19664713
Lancet Neurol. 2022 May;21(5):465-479
pubmed: 35334234
J Neurol. 1997 May;244 Suppl 2:S3-14
pubmed: 9178165
Neurobiol Dis. 2022 Dec;175:105927
pubmed: 36379394
J Neuroinflammation. 2020 Sep 26;17(1):283
pubmed: 32979923
Exp Cell Res. 2018 Dec 15;373(1-2):99-111
pubmed: 30342992
Physiol Rev. 2019 Jan 1;99(1):21-78
pubmed: 30280653
J Cell Mol Med. 2018 Oct;22(10):5151-5154
pubmed: 30054982
Free Radic Res. 2009 Apr;43(4):348-64
pubmed: 19241241
Neurol Sci. 2022 May;43(5):3201-3210
pubmed: 34826032
Curr Med Chem. 2014;21(31):3508-34
pubmed: 24934358
Nat Med. 2013 Dec;19(12):1584-96
pubmed: 24309662
Int J Mol Sci. 2022 Sep 21;23(19):
pubmed: 36232365
Nat Rev Dis Primers. 2017 Oct 05;3:17071
pubmed: 28980624
Mol Neurodegener. 2022 Jan 24;17(1):11
pubmed: 35073950
Lancet Neurol. 2019 Feb;18(2):211-220
pubmed: 30663610
Brain Res. 2012 Aug 21;1469:114-28
pubmed: 22750125
J Pers Med. 2022 Jun 29;12(7):
pubmed: 35887567
Nat Rev Neurol. 2018 Mar;14(3):133-150
pubmed: 29377008
J Neurol. 2005 Sep;252(9):1067-73
pubmed: 15789126
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
Nat Neurosci. 2008 Apr;11(4):420-2
pubmed: 18344992
Exp Neurol. 2019 Jun;316:27-38
pubmed: 30974102
Brain Behav Immun. 2016 Jan;51:212-222
pubmed: 26321046
CNS Neurosci Ther. 2021 Jan;27(1):36-47
pubmed: 33381913
Neurology. 2006 Mar 28;66(6):852-6
pubmed: 16567701
PLoS One. 2007 Nov 21;2(11):e1205
pubmed: 18030339
J Neurol Sci. 1993 Aug;118(1):73-8
pubmed: 7693877
Brain Res. 2007 Jul 9;1157:126-37
pubmed: 17512910
Arterioscler Thromb Vasc Biol. 2002 Mar 1;22(3):438-42
pubmed: 11884287
Br J Pharmacol. 2022 Jun;179(11):2577-2588
pubmed: 35048358
Fluids Barriers CNS. 2020 Nov 18;17(1):69
pubmed: 33208141
Pharmaceutics. 2022 Dec 14;14(12):
pubmed: 36559296
Cell Biochem Biophys. 2018 Jun;76(1-2):265-271
pubmed: 28332021
Neurol Sci. 2023 May;44(5):1679-1685
pubmed: 36646859
Fluids Barriers CNS. 2020 Feb 5;17(1):14
pubmed: 32024544
Gend Med. 2010 Dec;7(6):557-70
pubmed: 21195356
Front Neurosci. 2021 Oct 29;15:656456
pubmed: 34776835
J Neurol. 2000 Mar;247 Suppl 1:I1-6
pubmed: 10795881
Science. 2006 Oct 6;314(5796):130-3
pubmed: 17023659
Front Cell Neurosci. 2022 Mar 31;16:851563
pubmed: 35431812

Auteurs

Hugo Alarcan (H)

Laboratoire de Biochimie et Biologie Moléculaire, CHRU Bretonneau, 2 Boulevard Tonnellé, 37000 Tours, France.
UMR 1253 iBrain, Université de Tours, Inserm, 10 Boulevard Tonnellé, 37000 Tours, France.

Patrick Vourc'h (P)

Laboratoire de Biochimie et Biologie Moléculaire, CHRU Bretonneau, 2 Boulevard Tonnellé, 37000 Tours, France.
UMR 1253 iBrain, Université de Tours, Inserm, 10 Boulevard Tonnellé, 37000 Tours, France.

Lise Berton (L)

Laboratoire de Biochimie et Biologie Moléculaire, CHRU Bretonneau, 2 Boulevard Tonnellé, 37000 Tours, France.

Isabelle Benz-De Bretagne (I)

Laboratoire de Biochimie et Biologie Moléculaire, CHRU Bretonneau, 2 Boulevard Tonnellé, 37000 Tours, France.

Eric Piver (E)

Laboratoire de Biochimie et Biologie Moléculaire, CHRU Bretonneau, 2 Boulevard Tonnellé, 37000 Tours, France.

Christian R Andres (CR)

Laboratoire de Biochimie et Biologie Moléculaire, CHRU Bretonneau, 2 Boulevard Tonnellé, 37000 Tours, France.
UMR 1253 iBrain, Université de Tours, Inserm, 10 Boulevard Tonnellé, 37000 Tours, France.

Philippe Corcia (P)

UMR 1253 iBrain, Université de Tours, Inserm, 10 Boulevard Tonnellé, 37000 Tours, France.
Service de Neurologie, CHRU Bretonneau, 2 Boulevard Tonnellé, 37000 Tours, France.

Charlotte Veyrat-Durebex (C)

Laboratoire de Biochimie et Biologie Moléculaire, CHRU Bretonneau, 2 Boulevard Tonnellé, 37000 Tours, France.
UMR 1253 iBrain, Université de Tours, Inserm, 10 Boulevard Tonnellé, 37000 Tours, France.

Hélène Blasco (H)

Laboratoire de Biochimie et Biologie Moléculaire, CHRU Bretonneau, 2 Boulevard Tonnellé, 37000 Tours, France.
UMR 1253 iBrain, Université de Tours, Inserm, 10 Boulevard Tonnellé, 37000 Tours, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH